The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

If current trends continue, North America could soon become a hotspot for permanent measles transmission. Canada could lose ...

Canada is poised to lose its measles elimination status after nearly three decades, and public health experts fear outbreaks ...

Canada eliminated measles in 1998. The U.S. followed two years later, in 2000. There are multiple criteria for losing an ...

Interprovincial credential recognition, funding agreements, mental health and addiction issues, and vaccination programs are ...

Dental Care Plan members are being notified of changes to their coverage after an internal error was identified ...